Bristol-Myers Squibb Company

BMY

New York Stock Exchange. Currency in USD

78.83 -1.05 ( -1.31% )

Real time prices: December 09

Market Cap.
167.61B
Beta (5Y monthly)
0.39
Price/Earnings
10.49
EPS (TTM)
7.71
Forward Dividend
2.16 (2.70%)
Ex-Dividend Date
Oct 07, 2022
Volume
8.83M
1y Target Est.
80.88
Day's Range
78.73
-
80.67
52 Week's Range
56.11
-
81.44

Historical Summary

Performance
EPS growth
Share Buybacks

About Bristol-Myers Squibb Company

Sector
Healthcare
Industry
Drug Manufacturers-General
Website
https://www.bms.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
2.22B
Employees
32200
Address
430 East 29th Street, New York, NY, United States, 10016
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

Latest news

bluebird (BLUE) to Boost Cash With Priority Review Voucher Sale
bluebird (BLUE) to Boost Cash With Priority Review Voucher Sale

bluebird (BLUE) is set to sell one of its two priority review vouchers. This will...
By Zacks Investment Research - 1 week ago

The Top Healthcare Stocks to Buy With $100
The Top Healthcare Stocks to Buy With $100

Triple-digit growth and innovation go hand-in-hand with these companies.
By The Motley Fool - 1 week ago

Are Tech Layoffs Going to Be a Headache for Alexandria Real Estate Equities?
Are Tech Layoffs Going to Be a Headache for Alexandria Real Estate Equities?

Tech layoffs are in the news, but life sciences companies seem to be doing better.
By The Motley Fool - 1 week ago

2 Massive Companies That Have Doubled Their Sales in 5 Years
2 Massive Companies That Have Doubled Their Sales in 5 Years

Mergers and acquisitions have played a big part in the growth of these businesses.
By The Motley Fool - 1 week ago

Alexandria Real Estate Stock: Bull vs. Bear
Alexandria Real Estate Stock: Bull vs. Bear

Is Alexandria Real Estate worth the price?
By The Motley Fool - 1 week ago

Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session

Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it...
By Benzinga - 1 week ago

US Stocks Start Week On Lower Note, Dow Drops Over 100 Points
US Stocks Start Week On Lower Note, Dow Drops Over 100 Points

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points...
By Benzinga - 1 week ago

3 Dividend Stocks to Hold Forever
3 Dividend Stocks to Hold Forever

These businesses -- and dividends -- are built to last.
By The Motley Fool - 1 week ago